sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19

Recruiting Phase 3 Interventional Study
Post-COVID POST-Covid 19 Post-COVID Conditions
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Fatigue, cognitive problems, post-exertional malaise (PEM) and postural orthostatic tachycardia syndrome (POTS) are common and debilitating symptoms after COVID-19. The pathophysiology of post-COVID is not well understood and there is no established biomedical treatment. Treatment options for post-COVID are thus much needed. A promising candidate intervention is fluvoxamine, a selective serotonin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged 18 to 70 years * Severely fatigued (CIS fatigue score ≥ 35) at screening * Fatigue started/increased significantly after Covid-19 (self-declared) * Fatigue symptoms must be present for at least 3 months following the acute infection. * Self-reported confirmation of…
Contacts

No contact information available.